Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys

Louisa Degenhardt; Chrianna Bharat; Wai Tat Chiu; Meredith G. Harris; Alan E. Kazdin; Daniel V. Vigo; Nancy A. Sampson; Jordi Alonso; Laura Helena Andrade; Ronny Bruffaerts; Brendan Bunting; Graca Cardoso; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Aimee N. Karam; Elie G. Karam; Viviane Kovess-Masfety; Sing Lee; Victor Makanjuola; John J. McGrath; Maria Elena Medina-Mora; Jacek Moskalewicz; Fernando Navarro-Mateu; Jose Posada-Villa; Charlene Rapsey; Juan Carlos Stagnaro; Hisateru Tachimori; Margreet ten Have; Yolanda Torres; David R. Williams; Zahari Zarkov; Ronald C. Kessler; WHO World Mental Hlth Survey Colla

doi:10.1016/j.drugalcdep.2021.109158

Back

Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys

Journal article

Peer reviewed

Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys

Louisa Degenhardt, Chrianna Bharat, Wai Tat Chiu, Meredith G. Harris, Alan E. Kazdin, Daniel V. Vigo, Nancy A. Sampson, Jordi Alonso, Laura Helena Andrade, Ronny Bruffaerts, …

Drug and alcohol dependence, Vol.229(Pt B), pp.109158-109158

01/12/2021

DOI: https://doi.org/10.1016/j.drugalcdep.2021.109158

Handle:

https://hdl.handle.net/10523/18514

Abstract

Life Sciences & Biomedicine

Psychiatry

Science & Technology

Substance Abuse

Aim: We examined prevalence and factors associated with receiving perceived helpful alcohol use disorder (AUD) treatment, and persistence in help-seeking after earlier unhelpful treatment. Methods: Data came from 27 community epidemiologic surveys of adults in 24 countries using the World Health Organization World Mental Health surveys (n = 93,843). Participants with a lifetime history of treated AUD were asked if they ever received helpful AUD treatment, and how many professionals they had talked to up to and including the first time they received helpful treatment (or how many ever, if they had not received helpful treatment). Results: 11.8% of respondents with lifetime AUD reported ever obtaining treatment (n = 9378); of these, 44% reported that treatment was helpful. The probability of obtaining helpful treatment from the first professional seen was 21.8%; the conditional probability of subsequent professionals being helpful after earlier unhelpful treatment tended to decrease as more professionals were seen. The cumulative probability of receiving helpful treatment at least once increased from 21.8% after the first professional to 79.7% after the seventh professional seen, following earlier unhelpful treatment. However, the cumulative probability of persisting with up to seven professionals in the face of prior treatments being unhelpful was only 13.2%. Conclusion: Fewer than half of people with AUDs who sought treatment found treatment helpful; the most important factor was persistence in seeking further treatment if a previous professional had not helped. Future research should examine how to increase the likelihood that AUD treatment is found to be helpful on any given contact.

Metrics

8 Record Views

6 Times Cited - Web of Science

See more details

Details

Record Identifier: 9926495352301891
Title: Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys
Creators: Louisa Degenhardt
Chrianna Bharat
Wai Tat Chiu
Meredith G. Harris
Alan E. Kazdin
Daniel V. Vigo
Nancy A. Sampson
Jordi Alonso
Laura Helena Andrade
Ronny Bruffaerts
Brendan Bunting
Graca Cardoso
Giovanni de Girolamo
Silvia Florescu
Oye Gureje
Josep Maria Haro
Chiyi Hu
Aimee N. Karam
Elie G. Karam
Viviane Kovess-Masfety
Sing Lee
Victor Makanjuola
John J. McGrath
Maria Elena Medina-Mora
Jacek Moskalewicz
Fernando Navarro-Mateu
Jose Posada-Villa
Charlene Rapsey
Juan Carlos Stagnaro
Hisateru Tachimori
Margreet ten Have
Yolanda Torres
David R. Williams
Zahari Zarkov
Ronald C. Kessler
WHO World Mental Hlth Survey Colla
Publication Details: Drug and alcohol dependence, Vol.229(Pt B), pp.109158-109158
Academic Unit: Psychological Medicine (DSM)
Publisher: Elsevier
Grant note: National Center for Public Health Protection WHO (Geneva); World Health Organization Ministry of Social Protection Algorithm National Institute of Health of the Ministry of Health of Peru UNSW Scientia PhD Scholarship R01DA1104470 / US a National Institute of Health (NIH) National Institute on Drug Abuse (NIDA) R01-MH059575 / US National Institute of Mental Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) Eli Lilly and Company; Eli Lilly R03 TW006481-01 / National Institute of Health/Fogarty International Center; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC) WHO (Nigeria); World Health Organization Health Research Council; Health Research Council of New Zealand Lundbeck; Lundbeck Corporation Fundacion para la Formacion e Investigacion Sanitarias (FFIS) of Murcia Glaxo Smith Kline; GlaxoSmithKline INPRFMDIES 4280 / National Institute of Psychiatry Ramon de la Fuente OmniPharma Health & Social Care Research & Development Division of the Public Health Agency 1135991 / NHMRC Senior Principal Research Fellowship; National Health and Medical Research Council (NHMRC) of Australia 044708 / Robert Wood Johnson Foundation (RWJF) FIS 00/0028 / Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain; Instituto de Salud Carlos III Eli Lilly Servier Ministry of Health Pfizer Pan American Health Organization PL 0256 / Institute of Psychiatry and Neurology in Warsaw WHO (Lebanon); World Health Organization 307933/2019-9 / Brazilian Council for Scientific and Technological Development (CNPq); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) South African Department of Health University of Michigan; University of Michigan System CON-ACyT-G30544-H / National Council on Science and Technology R01 MH070884 / United States National Institute of Mental Health (NIMH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) Center for Excellence on Research in Mental Health (CES University) Norwegian Financial Mechanism SAF 2000-158-CE / Ministerio de Ciencia y Tecnologia, Spain; Spanish Government Bella Pharma Champalimaud Foundation Alcohol Advisory Council Ortho-McNeil Pharmaceutical Inc. 2017 SGR 452; 2014 SGR 748 / DIUE de la Generalitat de Catalunya; Generalitat de Catalunya Lebanese Ministry of Public Health Bristol-Myers Squibb Australian Government Department of Health and Ageing; Australian Government; Department of Health & Ageing Gulbenkian Foundation Ministry of Public Health European Economic Area Financial Mechanism 03/00204-3 / Sao Paulo Research Foundation (FAPESP) Thematic Project; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) CIBER CB06/02/0046; RETICS RD06/0011 REM-TAP / Instituto de Salud Carlos III; Spanish Government UPO Polish Ministry of Health Pfizer Foundation 2002-17270/13-5 / Argentinian Ministry of Health (Ministerio de Salud de la Nacion) National Drug and Alcohol Research Centre PhD Scholarship National Institute of Drug Abuse; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA) European Economic Area Grant Israel National Institute for Health Policy and Health Services Research Departament de Salut, Generalitat de Catalunya, Spain; Generalitat de Catalunya Phenicia R13-MH066849; R01-MH069864; R01 DA016558 / United States Public Health Service; United States Department of Health & Human Services Catherine T. Mac-Arthur Foundation Australian Government Department of Health under the Drug and Alcohol Program Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social) AstraZeneca Foundation for Science and Technology (FCT); Fundacao para a Ciencia e a Tecnologia (FCT) H13-SHOGAI-023; H14-TOKUBETSU-026; H16-KOKORO-013; H25-SEISHIN-IPPAN-006 / Japan Ministry of Health, Labour and Welfare; Ministry of Health, Labour and Welfare, Japan Benta Novartis U01-MH60220 / National Institute of Mental Health (NIMH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) Secretary of Health of Medellin New Zealand Ministry of Health FIRCA R03-TW006481 / Fogarty International Center; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC) GlaxoSmithKline National Insurance Institute of Israel Federal Ministry of Health, Abuja, Nigeria QLG5-1999-01042; SANCO 2004123; EAHC 20081308 / European Commission; European Union (EU); European Commission Joint Research Centre
Date published ; e-published: 01/12/2021
Language: English
Resource Type ; Subtype: Journal article

Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys

Abstract

Related links

Metrics

Details